Eric A. Wold

1.9k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Eric A. Wold is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eric A. Wold has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Eric A. Wold's work include Receptor Mechanisms and Signaling (7 papers), Bioactive Natural Diterpenoids Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Eric A. Wold is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Bioactive Natural Diterpenoids Research (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Eric A. Wold collaborates with scholars based in United States, China and France. Eric A. Wold's co-authors include Jia Zhou, Haiying Chen, Na Ye, Pei‐Yong Shi, Zhiqing Liu, Pingyuan Wang, Ye Ding, Allan R. Brasier, Bing Tian and Kathryn A. Cunningham and has published in prestigious journals such as Cancer Research, Environmental Health Perspectives and International Journal of Molecular Sciences.

In The Last Decade

Eric A. Wold

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic Potential of Spirooxindoles as Antiviral Agents

2016 412 citations Na Ye, Haiying Chen et al. ACS Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric A. Wold United States	16	900	512	176	171	111	31	1.5k
Jinpei Zhou China	22	745 0.8×	474 0.9×	50 0.3×	111 0.6×	80 0.7×	90	1.4k
Emanuele Amata Italy	27	1.0k 1.2×	393 0.8×	227 1.3×	35 0.2×	187 1.7×	75	1.6k
Maria Paola Giovannoni Italy	24	939 1.0×	812 1.6×	150 0.9×	34 0.2×	267 2.4×	106	1.8k
Yanhua Mou China	20	1.4k 1.5×	286 0.6×	57 0.3×	66 0.4×	144 1.3×	52	2.5k
Elisabetta Orlandini Italy	25	869 1.0×	524 1.0×	68 0.4×	41 0.2×	239 2.2×	103	1.7k
Yukihiro Itoh Japan	30	2.3k 2.6×	487 1.0×	100 0.6×	213 1.2×	90 0.8×	77	3.0k
Markus Pietsch Germany	20	461 0.5×	348 0.7×	78 0.4×	33 0.2×	145 1.3×	53	982
Navnath S. Gavande United States	20	791 0.9×	215 0.4×	126 0.7×	18 0.1×	84 0.8×	52	1.2k
Sunjoo Ahn South Korea	21	568 0.6×	433 0.8×	33 0.2×	43 0.3×	76 0.7×	58	1.2k
Li-Fang Yu China	24	853 0.9×	430 0.8×	67 0.4×	18 0.1×	243 2.2×	63	1.4k

Countries citing papers authored by Eric A. Wold

Since Specialization

Citations

This map shows the geographic impact of Eric A. Wold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Wold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Wold more than expected).

Fields of papers citing papers by Eric A. Wold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Wold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Wold. The network helps show where Eric A. Wold may publish in the future.

Co-authorship network of co-authors of Eric A. Wold

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Wold. A scholar is included among the top collaborators of Eric A. Wold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Wold. Eric A. Wold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fox, Robert G., Christopher Wild, Eric A. Wold, et al.. (2024). Serendipitous Discovery of Novel 5-HT2AR Positive Allosteric Modulators (PAMs) Derived From 5-HT2CR PAM Scaffolds. Journal of Pharmacology and Experimental Therapeutics. 389. 87–87.

Chen, Jianping, Konrad Pazdrak, Susan Stafford, et al.. (2023). Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT_2C Receptor and Dual 5-HT_2C/5-HT_2A Receptor Modulators. Journal of Medicinal Chemistry. 66(14). 9992–10009. 7 indexed citations

Liu, Zhiqing, Yi Li, Haiying Chen, et al.. (2022). Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Journal of Medicinal Chemistry. 65(3). 2388–2408. 44 indexed citations

Xu, Jimin, Judith Berastegui‐Cabrera, Marta Carretero-Ledesma, et al.. (2021). Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome. International Journal of Molecular Sciences. 22(4). 1617–1617. 7 indexed citations

Wold, Eric A., Abhay Dhand, Aromma Kapoor, et al.. (2021). The Potential Impact of Mammographic Breast Arterial Calcification On Physician Practices in a Primary Care Setting. Future Cardiology. 17(7). 1241–1248. 5 indexed citations

Wold, Eric A., Christopher Wild, Joanna Miszkiel, et al.. (2020). Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT_2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. Journal of Medicinal Chemistry. 63(14). 7529–7544. 15 indexed citations

Ye, Na, Sheng Tian, Qingfeng Xu, et al.. (2020). Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. Journal of Medicinal Chemistry. 63(24). 15187–15217. 61 indexed citations

Liu, Gang, Tao Yin, Hyejin Kim, et al.. (2019). Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer. European Journal of Medicinal Chemistry. 178. 589–605. 14 indexed citations

Wold, Eric A., Christopher Wild, Kathryn A. Cunningham, & Jia Zhou. (2019). Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. Current Topics in Medicinal Chemistry. 19(16). 1381–1398. 41 indexed citations

10.

Ye, Na, Bang Li, Qi Mao, et al.. (2018). Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target. ACS Chemical Neuroscience. 10(1). 190–200. 26 indexed citations

11.

Ding, Ye, Dengfeng Li, Chunyong Ding, et al.. (2018). Abstract 2668: Regio- and stereospecific synthesis of oridonin D-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent warheads. Cancer Research. 78(13_Supplement). 2668–2668.

12.

Ding, Ye, Dengfeng Li, Chunyong Ding, et al.. (2018). Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads. Journal of Medicinal Chemistry. 61(7). 2737–2752. 37 indexed citations

13.

Liu, Zhiqing, Pingyuan Wang, Haiying Chen, et al.. (2017). Drug Discovery Targeting Bromodomain-Containing Protein 4. Journal of Medicinal Chemistry. 60(11). 4533–4558. 235 indexed citations

14.

Ding, Ye, Chunyong Ding, Na Ye, et al.. (2016). Discovery and development of natural product oridonin-inspired anticancer agents. European Journal of Medicinal Chemistry. 122. 102–117. 148 indexed citations

15.

Ye, Na, Haiying Chen, Eric A. Wold, Pei‐Yong Shi, & Jia Zhou. (2016). Therapeutic Potential of Spirooxindoles as Antiviral Agents. ACS Infectious Diseases. 2(6). 382–392. 412 indexed citations breakdown →

16.

Shearer, Joseph J., et al.. (2015). Inorganic Arsenic–Related Changes in the Stromal Tumor Microenvironment in a Prostate Cancer Cell–Conditioned Media Model. Environmental Health Perspectives. 124(7). 1009–1015. 15 indexed citations

17.

Liu, Zhiqing, Christopher Wild, Ye Ding, et al.. (2015). BH4 domain of Bcl-2 as a novel target for cancer therapy. Drug Discovery Today. 21(6). 989–996. 43 indexed citations

18.

Wold, Eric A., et al.. (2014). Chitosan and chitosan composites reinforced with carbon nanostructures. Journal of Alloys and Compounds. 615. S515–S521. 8 indexed citations

19.

Nabors, Christopher, Stephen J. Peterson, Wilbert S. Aronow, et al.. (2013). Mobile Physician Reporting of Clinically Significant Events—A Novel Way to Improve Handoff Communication and Supervision of Resident on Call Activities. Journal of Patient Safety. 10(4). 211–217. 10 indexed citations

20.

Wold, Eric A., et al.. (2005). Clostridium Difficile Colitis Causing Rhabdomyolysis. The American Journal of Gastroenterology. 100. S170–S171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact